What is the appropriate cephalexin dosing for hidradenitis suppurativa in a patient who is 28 weeks pregnant?

Cephalexin Dosing for Hidradenitis Suppurativa at 28 Weeks Pregnancy

Use oral cephalexin 500 mg every 12 hours or 250 mg every 6 hours (1-4 grams daily in divided doses) for hidradenitis suppurativa in pregnancy, as it is safe and recommended by the most recent North American guidelines. 1

Recommendation Basis

The 2025 North American Clinical Practice Guidelines for HS in special populations provide a conditional recommendation with moderate quality evidence specifically endorsing oral cephalexin as safe for pregnant patients with HS requiring systemic antibiotics 1. This represents the most current, authoritative guidance available.

Safety Profile in Pregnancy

• Cephalexin crosses the placenta and reaches adequate levels in amniotic fluid and cord serum, but studies in non-HS pregnant patients demonstrate no adverse effects or increased risks of congenital anomalies 1
• Evidence from pregnancy studies shows cephalexin achieves therapeutic concentrations without significant maternal or fetal complications 2
• The FDA label confirms standard adult dosing of 1-4 grams daily in divided doses 3

Specific Dosing Algorithm

For mild-to-moderate HS:

• Start with 500 mg every 12 hours (1 gram daily)
• This is the standard dose for skin and skin structure infections per FDA labeling 3

For more severe disease or less susceptible organisms:

• Increase to 500 mg every 6 hours (2 grams daily) or higher
• Maximum 4 grams daily in divided doses 3
• If >4 grams daily needed, consider parenteral cephalosporins or alternative agents 3

Alternative Safe Options in Pregnancy

If cephalexin fails or is not tolerated, the guidelines support:

1. Azithromycin - conditional recommendation, moderate quality evidence 1
2. Clindamycin monotherapy - conditional recommendation, moderate quality evidence 1
3. Rifampin plus clindamycin combination - for severe disease only, conditional recommendation with very low quality evidence (rifampin is CDC/WHO-endorsed for TB in pregnancy, supporting safety) 1

Critical Medications to AVOID

Strongly avoid these antibiotics during pregnancy due to fetal risks:

• Doxycycline - congenital anomalies, bone binding, tooth discoloration (strong recommendation) 1
• Erythromycin - elevated liver enzymes and adverse outcomes (strong recommendation) 1
• Co-trimoxazole (TMP-SMX) - preterm birth, low birthweight, kernicterus 1
• Metronidazole - low birthweight, neuroblastoma risk 1
• Dapsone - preterm birth, low birthweight, hemolysis 1

Clinical Pearls

• Duration: Continue treatment throughout pregnancy as needed; HS commonly flares postpartum in >50% of women 4
• Monitoring: Assess response at 2-4 weeks; if inadequate, escalate dose before switching agents
• Combination approach: Consider adding topical chlorhexidine washes or zinc supplementation (strong recommendation for zinc, moderate quality) 1
• Severe flares: Intralesional steroids for acute localized lesions or short-course prednisone for widespread flares are options 1

Common Pitfall

Do not withhold effective antibiotic therapy due to pregnancy concerns—untreated HS causes significant morbidity and quality of life impairment that outweighs the minimal risks of cephalexin 5, 4. The evidence consistently supports cephalexin safety, and therapeutic nihilism harms both mother and pregnancy outcomes through uncontrolled inflammation and infection.